Resource feature: Behind the headlines

A good resource, well worth a look – the excellent ‘Behind the Headlines’ facility which is part of the larger, more well known NHS Choices website.  

BTHcategoriesBehind the headlines (BTH) looks at stories in the media to expand and explain how the headline came about.  If you read the article below, you will see how BTH traces the evidence back to the original research and provides an unbiased conclusion.

Hip replacement deaths drop by a half since 2003 

“Death rates following hip replacement surgery fell by half in England and Wales,” reports the BBC News website.

Its headline is based on a new study in The Lancet which looked at data from the National Joint Registry (NJR) over the course of eight years. The registry is an NHS database recording outcomes in artificial joint operations such as hip and knee replacements.

Read the full article, which includes research, a video and an easy to follow conclusion.

Advertisements

NICE guidance – updates

Keeping you up-to-datenice 1

Guidance by topic: the following guidance topics matching your health area preferences have been published or updated

 

Health Matters – 2 July 2013

The latest ‘Health Matters’ talk will be looking at the Rapid Recovery Joint Replacement Programme the trust adopted earlier this year. The talk, ‘Knee and Hip Replacements, working together for a quicker, better and happier recovery’, will be led by Mr Graham Keys, Consultant Orthopaedic Surgeon & Project Lead.

Other speakers at the lecture include Dr Mick Rothwell, Consultant Anaesthetist and the author of the Anaesthesia and Analgesic Protocol; Christine Jackson, Occupational Therapist; Shirley Jones, Perioperative Specialist Practitioner; Selena King, Ward Six Manager; Sarah Clubley, Physiotherapist and Dot Pearson, Acute Pain Nurse and Project Co-ordinator. Several patients who have already been through the programme will also be on hand at the event.

For further information on ‘Health Matters’ and to book your place at the 2 July lecture, from 7-8pm, in the Lecture Theatre, Macclesfield District General Hospital, please contact The Communications and Engagement Department on 01625 661560 or email ecntstaff.comms@nhs.net

This month in Eyes on Evidence

Data from the National Joint Registry for England and Wales indicates high failure rates for metal-on-metal hip replacements.
A Cochrane review shows cognitive stimulation therapies have beneficial effects on memory and thinking in people with dementia, as well as positive effects for wellbeing.
Developing more integrated support for people with mental and physical health problems could improve outcomes, by recognising the role of emotional and mental health problems in reducing people’s ability and motivation to manage their physical health.

Do renin-angiotensin system drugs reduce mortality in hypertension?

This systematic review provides good quality clinical evidence that  angiotensin-converting enzyme inhibitors reduce the risk of death in patients with hypertension. The benefits of angiotensin receptor blockers in reducing mortality are uncertain.
Angiotensin receptor blockers (ARBs) are no better than placebo or angiotensin-converting enzyme  inhibitors in reducing the risk of death, disability, or hospital admission for any reason. However, more patients stopped treatment early with ARBs than with placebo due to side effects.
An example from the Quality, Innovation, Productivity and Prevention collection on how the University Hospitals of Leicester NHS Trust has reduced delays, complications and costs around central venous access for patients.
Potential disinvestment opportunities highlighted this month are:
  • Biofeedback training for the management of faecal incontinence in children.
  • Non-pharmacological interventions for breathlessness.

Evidence Updates

This month NICE has published online via NHS Evidence an Evidence Update on constipation in children and young people.
How to get access, via NHS Athens on Apple and Android devices, to authoritative and practical information on the selection and clinical use of medicines from the British National Formulary.